Adaptive Biotechnologies Corporation (NASDAQ:ADPT – Get Free Report) COO Julie Rubinstein sold 11,881 shares of the stock in a transaction dated Friday, October 23rd. The stock was sold at an average price of $24.98, for a total transaction of $296,787.38. Following the transaction, the chief operating officer directly owned 377,802 shares of the company’s stock, […]

Adaptive Biotechnologies Corporation (NASDAQ:ADPT – Get Free Report) COO Julie Rubinstein sold 11,881 shares of the firm’s stock in a transaction dated Thursday, October 15th. The stock was sold at an average price of $25.61, for a total transaction of $304,272.41. Following the completion of the sale, the chief operating officer owned 377,802 shares of […]

Adaptive Biotechnologies Corporation (NASDAQ:ADPT – Get Free Report) COO Julie Rubinstein sold 11,881 shares of the company’s stock in a transaction that occurred on Tuesday, October 13th. The stock was sold at an average price of $25.50, for a total value of $302,965.50. Following the sale, the chief operating officer owned 377,802 shares of the […]